Value Sense
HIMS
Hims & Hers Health, Inc. (HIMS)
Last Price$40.7(9.8%)
Market Cap$9,261.6M
LTM Return on Equity (ROE)
27.5%
5Y avg
(12.2%)
Household & Personal Products industry median
10.1%
Stock quality & Intrinsic value
7/10
(0.5%) overvalued
HIMS
is (45.4%) overvalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

Hims & Hers Health, Inc. Return on Equity (ROE)

Annual
Quarterly
LTM
Industry median
Company stand-alone
HIMS
Consumer Defensive
Crunching data... Almost there!
Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Return on Equity (ROE)
(330.1%)
128.1%
12.8%
(114.7%)
(20.3%)
(7.2%)
HIMS
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for HIMS and see if it's the right time to invest.
Dive in

Hims & Hers Health, Inc. (HIMS) Return on Equity (ROE) comparison analysis

General

LTM Return on Equity (ROE)

OTHER METRICS

Company name

Revenue growth

EPS growth

Net Income margin

Hims & Hers Health, Inc. logo
Hims & Hers Health, Inc.HIMS
27.5%
65.5%
(65.6%)
(2.7%)
Median Peer Set
21.6%
2.1%
(4.3%)
10.2%
Colgate-Palmolive Company logo
Colgate-Palmolive CompanyCL
430.1%
3.3%
27.0%
14.4%
The Clorox Company logo
The Clorox CompanyCLX
268.4%
(4.0%)
86.0%
3.9%
Kimberly-Clark Corporation logo
Kimberly-Clark CorporationKMB
210.9%
(1.8%)
45.5%
12.7%
Unilever PLC logo
Unilever PLCUL
53.7%
1.8%
(12.4%)
10.9%
The Procter & Gamble Company logo
The Procter & Gamble CompanyPG
30.0%
2.5%
3.8%
17.7%
e.l.f. Beauty, Inc. logo
e.l.f. Beauty, Inc.ELF
13.2%
76.9%
99.1%
12.5%
Church & Dwight Co., Inc. logo
Church & Dwight Co., Inc.CHD
12.2%
4.1%
(22.7%)
9.6%
Kenvue Inc. logo
Kenvue Inc.KVUE
10.1%
0.1%
(40.0%)
6.7%
Coty Inc. logo
Coty Inc.COTY
0.8%
10.2%
(85.0%)
1.5%
The Estée Lauder Companies Inc. logo
The Estée Lauder Companies Inc.EL
(15.1%)
(1.9%)
(61.2%)
2.5%

HIMS key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Revenue
% growth
26.7
0.0%
82.6
209.4%
148.8
80.2%
271.9
82.8%
526.9
93.8%
872.0
65.5%
Cost of Goods Sold (COGS)18.938.039.367.4118.2157.1
Gross Profit
% margin
7.8
29.2%
44.6
54.0%
109.5
73.6%
204.5
75.2%
408.7
77.6%
714.9
82.0%
Operating Expenses83.6119.0124.6319.5477.4744.4
Research & Development Expenses (R&D)0.00.011.222.429.248.2
Selling, General & Administrative Expenses (SG&A)83.6119.0124.6319.5370.8692.7
Operating Income
% margin
(75.8)
(284.0%)
(74.4)
(90.1%)
(15.1)
(10.2%)
(115.0)
(42.3%)
(68.7)
(13.0%)
(29.5)
(3.4%)
Interest Income0.61.90.40.42.60.0
Interest Expense0.00.40.00.00.00.0
Pre-tax Income(75.2)(72.0)(18.0)(110.8)(65.7)(21.6)
Income Tax
% effective tax rate
0.0
(0.0%)
0.1
(0.1%)
0.1
(0.7%)
(3.1)
2.8%
(0.0)
0.0%
2.0
(9.2%)
Net Income
% margin
(75.2)
(282.0%)
(72.1)
(87.3%)
(18.1)
(12.2%)
(107.7)
(39.6%)
(65.7)
(12.5%)
(23.5)
(2.7%)
EPS(1.12)(2.86)(0.51)(0.58)(0.32)(0.11)
Diluted EPS(1.12)(2.86)(0.51)(0.58)(0.32)(0.11)
EBITDA
% margin
0.0
0.0%
(74.2)
(89.8%)
(14.1)
(9.5%)
(111.0)
(40.8%)
(61.2)
(11.6%)
(19.9)
(2.3%)

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
More ideas -->

FAQ

1) What is Hims & Hers Health, Inc.'s Return on Equity (ROE)?

As of today, Microsoft Corp's last 12-month Return on Equity (ROE) is 27.5%, based on the financial report for Dec 31, 2024 (Q4’2024). The average annual Return on Equity (ROE) for Hims & Hers Health, Inc. have been (11.4%) over the past three years, and (12.8%) over the past five years.

2) Is Hims & Hers Health, Inc.'s Return on Equity (ROE) Good?

As of today, Hims & Hers Health, Inc.'s Return on Equity (ROE) is 27.5%, which is higher than industry median of 10.1%. It indicates that Hims & Hers Health, Inc.'s Return on Equity (ROE) is Good.

3) How does Hims & Hers Health, Inc.'s Return on Equity (ROE) compare to its peers?

As of today, Hims & Hers Health, Inc.'s Return on Equity (ROE) is 27.5%, which is higher than peer median of 21.6%. The list of peers includes CL, CLX, KMB, UL, PG, ELF, CHD, KVUE, COTY, EL.